Cargando…

Economic Burden Associated with Extrapyramidal Symptoms in a Medicaid Population with Schizophrenia

No studies have assessed the economic impact of extrapyramidal symptoms due to atypical antipsychotics in schizophrenia. To assess healthcare resource use and medical costs associated with extrapyramidal symptoms in patients with schizophrenia. A retrospective analysis of Marketscan(®) Medicaid Mult...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abouzaid, Safiya, Tian, Haijun, Zhou, Huanxue, Kahler, Kristijan H., Harris, Michelle, Kim, Edward
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2012
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3895443/ https://www.ncbi.nlm.nih.gov/pubmed/23229052 http://dx.doi.org/10.1007/s10597-012-9561-7

Ejemplares similares

Economic burden in Medicaid beneficiaries with recently relapsed schizophrenia or with uncontrolled symptoms of schizophrenia not adherent to antipsychotics
por: Pilon, Dominic, et al.
Publicado: (2021)

Resource utilization, costs and treatment patterns of switching and discontinuing treatment of MS patients with high relapse activity
por: Raimundo, Karina, et al.
Publicado: (2013)

Economic Burden of COPD in the Presence of Comorbidities
por: Mannino, David M., et al.
Publicado: (2015)

Group-based trajectory modeling to assess adherence to biologics among patients with psoriasis
por: Li, Yunfeng, et al.
Publicado: (2014)

Study on risk factors of extrapyramidal symptoms induced by antipsychotics and its correlation with symptoms of schizophrenia
por: Weng, Jiajun, et al.
Publicado: (2019)

Escitalopram-induced extrapyramidal symptoms
por: Kumar, Pattath Narayanan Suresh, et al.
Publicado: (2019)

Long-lasting extrapyramidal symptoms after multiple injections of paliperidone palmitate to treat schizophrenia
por: Takada, Ryohei, et al.
Publicado: (2018)

FLUOXETINE INDUCED EXTRAPYRAMIDAL SYMPTOMS : CASE REPORTS
por: Nizamie, S. Haque, et al.
Publicado: (1998)

Chronic subdural haematoma mimicking extrapyramidal symptoms
por: Cheng, Po Wen, et al.
Publicado: (2023)

M216. ASSOCIATIONS OF EXTRAPYRAMIDAL SYMPTOMS WITH PSYCHOTIC SYMPTOMS IN A COHORT OF HOMELESS OR PRECARIOUSLY HOUSED PERSONS WITH OR WITHOUT SCHIZOPHRENIA
por: Kim, David, et al.
Publicado: (2020)

T205. LUMATEPERONE IN THE TREATMENT OF SCHIZOPHRENIA: EVALUATION OF EXTRAPYRAMIDAL AND MOTOR SYMPTOMS IN 4 LATE-PHASE CLINICAL TRIALS
por: Durgam, Suresh, et al.
Publicado: (2020)

The burden of cystic fibrosis in the Medicaid population
por: Hassan, Mariam, et al.
Publicado: (2018)

Improving pharmacogenetic prediction of extrapyramidal symptoms induced by antipsychotics
por: Boloc, Daniel, et al.
Publicado: (2018)

Brainstem atrophy is linked to extrapyramidal symptoms in frontotemporal dementia
por: Heikkinen, Sami, et al.
Publicado: (2022)

Extrapyramidal side effects in first-episode schizophrenia treated with flupenthixol decanoate
por: Joubert, Francois-Pierre, et al.
Publicado: (2021)

Time to onset and time to resolution of extrapyramidal symptoms in patients with exacerbated schizophrenia treated with 3-monthly vs once-monthly paliperidone palmitate
por: Mathews, Maju, et al.
Publicado: (2018)

Analysis of the relationship between psoriasis symptom severity and quality of life, work productivity, and activity impairment among patients with moderate-to-severe psoriasis using structural equation modeling
por: Lewis-Beck, Colin, et al.
Publicado: (2013)

Acamprosate-induced Extrapyramidal Symptoms in an Elderly Patient with Alcohol Dependence
por: Woo, Jungmin, et al.
Publicado: (2014)

Extrapyramidal Symptoms with Administration of Lenalidomide Maintenance Therapy for Multiple Myeloma
por: Sagar, FNU, et al.
Publicado: (2018)

Association of CYP2D6 polymorphisms and extrapyramidal symptoms in schizophrenia patients receiving risperidone: a retrospective study
por: Ito, Takahiro, et al.
Publicado: (2018)

Relationship of serum homocysteine and vitamin D with positive, negative, and extrapyramidal symptoms in schizophrenia: a case–control study in Iran
por: Shahini, Najmeh, et al.
Publicado: (2022)

Cariprazine as a useful treatment for patients with schizophrenia and antipsychotic-induced extrapyramidal symptoms: a case report and literature review
por: Llach, C., et al.
Publicado: (2022)

Erratum: Extrapyramidal side effects in first-episode schizophrenia treated with flupenthixol decanoate
por: Joubert, Francois-Pierre, et al.
Publicado: (2021)

The economic burden of schizophrenia in Malaysia
por: Teoh, Siew Li, et al.
Publicado: (2017)

PM410. Comparison of 3-Monthly versus 1-Monthly Paliperidone Palmitate for Time to Onset and Time to Resolution of Extrapyramidal Symptoms in Patients with Exacerbated Schizophrenia
por: Mathews, Maju, et al.
Publicado: (2016)

Depression, extrapyramidal symptoms, dementia and an unexpected outcome: a case report
por: Tsolaki, Magda, et al.
Publicado: (2010)

Organophosphate intermediate syndrome with neurological complications of extrapyramidal symptoms in clinical practice
por: Detweiler, Mark B.
Publicado: (2014)

Aripiprazole and Acute Extrapyramidal Symptoms in Children and Adolescents: A Meta-Analysis
por: Bernagie, Chiara, et al.
Publicado: (2016)

Extrapyramidal symptoms after exposure to calcium channel blocker-flunarizine or cinnarizine
por: Jhang, Kai-Ming, et al.
Publicado: (2017)

Author Correction: Improving pharmacogenetic prediction of extrapyramidal symptoms induced by antipsychotics
por: Boloc, Daniel, et al.
Publicado: (2019)

Prevalence of Extrapyramidal Symptoms in In-Patients With Severe Mental Illnesses: Focus on Parkinsonism
por: Roiter, Beatrice, et al.
Publicado: (2020)

Extrapyramidal symptoms predict cognitive performance after first-episode psychosis
por: Lindgren, Maija, et al.
Publicado: (2022)

The Use of Amantadine in Treating Extrapyramidal Symptoms in Organophosphates Poisoning in a Child
por: Althaqafi, Wesam, et al.
Publicado: (2023)

Drug-Induced Extrapyramidal Syndromes
por: Lader, M. H.
Publicado: (1970)

Economic Burden of Schizophrenia in South Korea
por: Chang, Sung Man, et al.
Publicado: (2008)

High prevalence of extrapyramidal signs and symptoms in a group of Italian dental technicians
por: Fabrizio, Edito, et al.
Publicado: (2007)

Apolipoprotein E e4 allele is associated with extrapyramidal symptoms in Alzheimer’s disease
por: Chang, Yang-Pei, et al.
Publicado: (2019)

Assessment of Extrapyramidal Symptoms Associated with Psychotropics Pharmacological Treatments, and Associated Risk Factors
por: Abu-Naser, Dania, et al.
Publicado: (2021)

Exercise and Worsening of Extrapyramidal Symptoms during Treatment with Long-Acting Injectable Antipsychotics
por: Kim, David D., et al.
Publicado: (2021)

Genetic Variants in Diseases of the Extrapyramidal System
por: Oczkowska, Anna, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_ukkdncaj4mfsu1suq1rp7e65vo